Events Topic Topic TopicAll TopicsAccess to MedicinesAgriculture & FoodAntimicrobial Resistance (AMR)Child HealthClean Air, Transport & CitiesClean Cooking & HeatingClimate CrisisDigital HealthDiscriminationEPHA NewsEurope and HealthHealth WorkforceMental HealthNon Communicable Diseases (NCDs)ObesityPandemics & Infectious DiseasesRoma HealthSustainabilityTobacco Policy Policy PolicyAll PoliciesHealthy EnvironmentsHealthcare DeliveryHealth EquityHealth Systems and EconomyGlobal Public HealthDigital TransformationPolitics and Health Search Search Search Clear December 5, 20225th EPHA Universal Access and Affordable Medicines Forum5th EPHA Universal Access and Affordable Medicines Forum 09:00 – 17:00 21 Speakers Brussels The...Healthcare DeliveryPolitics and HealthAccess to MedicinesJanuary 18, 2022Transparency of (real) pharmaceutical costsTransparency of (real) pharmaceutical costs Join the second event of the Zooming in on Solution...Healthcare DeliveryAccess to MedicinesDecember 9, 2021European Cross-Border Initiatives: Towards Fair Medicine Deals?European Cross-Border Initiatives:Towards Fair Medicine Deals? This timely event will explore the challenges and opportunities...Healthcare DeliveryPolitics and HealthAccess to MedicinesJune 30, 2021Vaccines for all? Undocumented Migrants and Homeless People Left BehindJoin our discussion with Human Rights Watch and PICUM to discuss what still needs to...Healthcare DeliveryHealth EquityAccess to MedicinesDiscriminationJune 15, 2021The Oslo Medicines Initiative: a new social contract with pharmaJoin us for the eighth EPHA #A2MDialogues to discuss the Oslo Medicines InitiativeHealthcare DeliveryAccess to MedicinesMay 18, 2021Negotiating with pharma: Lessons from the EU COVID-19 vaccine negotiationsNegotiating with pharma:lessons from the EU COVID-19 vaccine negotiations Continuing our successful online discussions on...Healthcare DeliveryHealth Systems and EconomyAccess to MedicinesApril 22, 2021Why are we vaccine hesitant in a pandemic? Tools to boost confidence in vaccinesJoin us for EPHA’s second webinar as part of our #VaccineEquity campaign ahead of World...Healthcare DeliveryHealth EquityPandemics & Infectious DiseasesApril 15, 2021Sustainable access to effective antibiotics – what should the EU do?How can we solve the AMR epidemic? What is the role of the EU? What...Healthcare DeliveryPolitics and HealthAccess to MedicinesMarch 25, 2021Why and how should we prioritize marginalized communities in the rollout of COVID-19 vaccines in Europe?As COVID-19 vaccines are rolled out across Europe, why and how should we prioritize marginalized...Healthcare DeliveryAccess to MedicinesPandemics & Infectious DiseasesMarch 9, 2021After COVID-19, what’s next for EU medicines policies?Continuing our successful online discussions on key access to medicines (A2M) priorities launched in 2020,...Healthcare DeliveryAccess to MedicinesPandemics & Infectious DiseasesDecember 8, 2020Getting it right: Recommendations for a European BARDAJoin us for the fifth of the #A2MDialogues to discuss the development of an European...Healthcare DeliveryAccess to MedicinesNovember 25, 2020The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicinesEPHA’s fourth #A2MDialogue follows the publication of the EU’s Pharmaceutical Strategy by the European Commission....Healthcare DeliveryAccess to MedicinesNovember 19, 2020Pharma & COVID19: Winners, losers, prospectsFrom the onset of the COVID-19 pandemic, governments turned to the pharmaceutical sector for answers...Healthcare DeliveryAccess to MedicinesOctober 27, 2020The EU’s IP strategy: Enabler or barrier?EPHA’s second #A2MDialogue discussing the EU’s IP strategy and if it is a barrier or...Healthcare DeliveryAccess to MedicinesOctober 20, 2020Unleashing meaningful innovation through regulatory reformJoin EPHA for our first online Access to Medicines Dialogue to discuss how regulatory and...Healthcare DeliveryAccess to MedicinesPutting health firstEPHA hosts Medicines Law & Policy experts to launch a set of recommendations on incentives...Healthcare DeliveryOctober 3, 2018How good are our medicines?The session will draw the link between HTA and the regulatory environment and provide answers...Healthcare DeliveryAccess to MedicinesOctober 5, 2017Medicines: New game, new rulesMedicines: New Games, New Rules Pathways to better and affordable medicines Organised by Open Society...Healthcare DeliveryAccess to Medicines Load more Get the EPHA Newsletter SUBSCRIBE
December 5, 20225th EPHA Universal Access and Affordable Medicines Forum5th EPHA Universal Access and Affordable Medicines Forum 09:00 – 17:00 21 Speakers Brussels The...Healthcare DeliveryPolitics and HealthAccess to Medicines
January 18, 2022Transparency of (real) pharmaceutical costsTransparency of (real) pharmaceutical costs Join the second event of the Zooming in on Solution...Healthcare DeliveryAccess to Medicines
December 9, 2021European Cross-Border Initiatives: Towards Fair Medicine Deals?European Cross-Border Initiatives:Towards Fair Medicine Deals? This timely event will explore the challenges and opportunities...Healthcare DeliveryPolitics and HealthAccess to Medicines
June 30, 2021Vaccines for all? Undocumented Migrants and Homeless People Left BehindJoin our discussion with Human Rights Watch and PICUM to discuss what still needs to...Healthcare DeliveryHealth EquityAccess to MedicinesDiscrimination
June 15, 2021The Oslo Medicines Initiative: a new social contract with pharmaJoin us for the eighth EPHA #A2MDialogues to discuss the Oslo Medicines InitiativeHealthcare DeliveryAccess to Medicines
May 18, 2021Negotiating with pharma: Lessons from the EU COVID-19 vaccine negotiationsNegotiating with pharma:lessons from the EU COVID-19 vaccine negotiations Continuing our successful online discussions on...Healthcare DeliveryHealth Systems and EconomyAccess to Medicines
April 22, 2021Why are we vaccine hesitant in a pandemic? Tools to boost confidence in vaccinesJoin us for EPHA’s second webinar as part of our #VaccineEquity campaign ahead of World...Healthcare DeliveryHealth EquityPandemics & Infectious Diseases
April 15, 2021Sustainable access to effective antibiotics – what should the EU do?How can we solve the AMR epidemic? What is the role of the EU? What...Healthcare DeliveryPolitics and HealthAccess to Medicines
March 25, 2021Why and how should we prioritize marginalized communities in the rollout of COVID-19 vaccines in Europe?As COVID-19 vaccines are rolled out across Europe, why and how should we prioritize marginalized...Healthcare DeliveryAccess to MedicinesPandemics & Infectious Diseases
March 9, 2021After COVID-19, what’s next for EU medicines policies?Continuing our successful online discussions on key access to medicines (A2M) priorities launched in 2020,...Healthcare DeliveryAccess to MedicinesPandemics & Infectious Diseases
December 8, 2020Getting it right: Recommendations for a European BARDAJoin us for the fifth of the #A2MDialogues to discuss the development of an European...Healthcare DeliveryAccess to Medicines
November 25, 2020The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicinesEPHA’s fourth #A2MDialogue follows the publication of the EU’s Pharmaceutical Strategy by the European Commission....Healthcare DeliveryAccess to Medicines
November 19, 2020Pharma & COVID19: Winners, losers, prospectsFrom the onset of the COVID-19 pandemic, governments turned to the pharmaceutical sector for answers...Healthcare DeliveryAccess to Medicines
October 27, 2020The EU’s IP strategy: Enabler or barrier?EPHA’s second #A2MDialogue discussing the EU’s IP strategy and if it is a barrier or...Healthcare DeliveryAccess to Medicines
October 20, 2020Unleashing meaningful innovation through regulatory reformJoin EPHA for our first online Access to Medicines Dialogue to discuss how regulatory and...Healthcare DeliveryAccess to Medicines
Putting health firstEPHA hosts Medicines Law & Policy experts to launch a set of recommendations on incentives...Healthcare Delivery
October 3, 2018How good are our medicines?The session will draw the link between HTA and the regulatory environment and provide answers...Healthcare DeliveryAccess to Medicines
October 5, 2017Medicines: New game, new rulesMedicines: New Games, New Rules Pathways to better and affordable medicines Organised by Open Society...Healthcare DeliveryAccess to Medicines
